Clinical Trial Update: External Beam Radiotherapy and Zevalin for Management of Indolent B-Cell Non-Hodgkin's Lymphoma [Phase 1]

View source ↗

Summary

A Phase 1 study at the Cleveland Clinic evaluated combining external beam radiotherapy with Zevalin (ibritumomab tiuxetan) for indolent B-cell non-Hodgkin lymph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Zevalin (ibritumomab tiuxetan)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Lymphoma, B-Cell | Phase 1 | Status: COMPLETED